Point72 Middle East Fze Emergent Bio Solutions Inc. Transaction History

Point72 Middle East Fze

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.82 - $3.16 $238,682 - $414,415	-131,144 Reduced 61.81%	81,032 $194,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $672,597 - $1.68 Million	212,176 New	212,176 $721,000
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $283,057 - $591,913	36,336 New	36,336 $376,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.